Accellta Signs Exclusive Agreement With Stem Cell Technologies

April 15, 2015 | The Israeli stem cell solutions company Accellta announced that it signed an exclusive agreement with the international company Stem Cell Technologies. As part of the agreement, Stem Cell Technologies will market Accellta’s culturing platform that grows stem cells. Accellta was founded at the AMIT Institute of the Technion Israel Institute of Technology.